Zhen Jin | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Zhen Jin | Drug Delivery Systems | Best Researcher Award

Assistant Professor at Xinxiang Medical University | China

Dr. Zhen Jin is a distinguished researcher specializing in nanomedicine, controlled drug delivery, and medical micro-nano robots. He completed doctoral and postdoctoral research at the Medical Robotics Research Institute of Chonnam National University, South Korea, before joining Xinxiang Medical College. His innovative work integrates nanodrug design, advanced therapeutic delivery systems, and cancer diagnostics. With more than 30 SCI-indexed publications, including numerous first-author papers, and four granted national invention patents, his contributions continue to influence biomedical science. His pioneering developments in imaging-guided therapy and synergistic nanocomposites highlight his commitment to advancing cancer treatment and medical robotics research globally.

Publication Profile 

Google Scholar

Education 

Dr. Zhen Jin pursued his doctoral degree at the Medical Robotics Research Institute, Chonnam National University, South Korea, where he also completed postdoctoral research. His academic journey provided a strong foundation in interdisciplinary biomedical engineering, robotics, and nanomedicine. During this period, he engaged in multiple national-level projects, honing expertise in medical micro-nano systems and cancer therapy. This rigorous academic training prepared him to advance research in nanodrugs, controlled drug delivery, and medical robotics. Following this, he transitioned to Xinxiang Medical College, where he integrated his educational background into teaching and research to foster innovation in biomedical sciences.

Experience

Dr. Zhen Jin has extensive research and academic experience, beginning with his doctoral and postdoctoral tenure in South Korea, where he contributed to significant national key projects. His expertise spans nanodrug design, micro-nano robotics, and advanced cancer diagnosis and treatment technologies. Currently, he is a faculty member at Xinxiang Medical College, where he leads cutting-edge projects funded by Henan Province. He has successfully published more than 30 SCI papers, authored key innovations, and secured national invention patents. His experience bridges academia and applied research, positioning him as a leader in biomedical nanotechnology and precision therapeutic development.

Awards and Honors

Dr. Zhen Jin has received recognition for his outstanding contributions to biomedical science, particularly in the fields of nanomedicine and cancer therapy. He has successfully participated in national research projects in South Korea and led provincial-level science and technology projects in China. His impactful research has earned him four national invention patents and numerous publications in high-impact SCI journals. His citation index reflects his growing influence in scientific communities, with an h-index of 21. These honors underscore his position as a promising and innovative researcher, making him a strong candidate for the Best Researcher Award.

Research Focus

Dr. Zhen Jin’s research focuses on nanomedicine, controlled drug delivery systems, and micro-nano robotic platforms for cancer therapy. He has developed multifunctional nanocomposites that combine therapeutic delivery with imaging capabilities for precise diagnosis and treatment. His work on DOX-HSP ananotheranostics exemplifies his focus, showcasing biocompatibility, controlled drug release, and imaging-guided multimodal therapy. By integrating photothermal and chemotherapeutic effects, his studies demonstrate enhanced anti-tumor efficacy. His pioneering approach seeks to overcome challenges of premature drug release and tumor-specific targeting, positioning his research at the forefront of personalized medicine, cancer diagnostics, and next-generation biomedical technologies.

Publication Top Notes

Human adipose–derived mesenchymal stem cell–based medical microrobot system for knee cartilage regeneration in vivo

Hybrid-actuating macrophage-based microrobots for active cancer therapy

A magnetically guided self‐rolled microrobot for targeted drug delivery, real‐time X‐Ray imaging, and microrobot retrieval

A thermo-electromagnetically actuated microrobot for the targeted transport of therapeutic agents

A magnetically actuated microscaffold containing mesenchymal stem cells for articular cartilage repair

Multifunctional nanorobot system for active therapeutic delivery and synergistic chemo-photothermal therapy

A hybrid actuated microrobot using an electromagnetic field and flagellated bacteria for tumor‐targeting therapy

A soft-magnet-based drug-delivery module for active locomotive intestinal capsule endoscopy using an electromagnetic actuation system

High-fidelity bioelectronic muscular actuator based on porous carboxylate bacterial cellulose membrane

Dual tumor-targeted multifunctional magnetic hyaluronic acid micelles for enhanced MR imaging and combined photothermal-chemotherapy

Ecofriendly high-performance ionic soft actuators based on graphene-mediated cellulose acetate

Preparation of HIFU-triggered tumor-targeted hyaluronic acid micelles for controlled drug release and enhanced cellular uptake

Feasibility study of dual-targeting paclitaxel-loaded magnetic liposomes using electromagnetic actuation and macrophages

Shape memory alloy–based biopsy device for active locomotive intestinal capsule endoscope

Conclusion

Dr. Zhen Jin pioneering contributions in nanomedicine, micro-nano robots, and controlled drug delivery make him a highly deserving candidate for the Best Researcher Award. His combination of innovative patents, high-impact publications, and cutting-edge theranostic development reflects exceptional promise for shaping the future of biomedical science. With continued emphasis on clinical translation and international engagement, his work is poised to leave a transformative mark on cancer diagnosis and therapy.

Yilong Wang | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Yilong Wang | Drug Delivery Systems | Best Researcher Award

Prof Yilong Wang, Beijing Tiantan Hospital, Capital Medical University, China

Dr. Yilong Wang, Executive Vice President of Beijing Tiantan Hospital, Capital Medical University, is a distinguished neurologist and scientist. With an MD and PhD in Neurology, he has pioneered research in stroke and rare neurological disorders. Author of 301 impactful journal articles and holder of 12 patents, his innovative work spans drug delivery systems and precision medicine. Honored with the 2023 Paul Dudley White International Award, he has also authored several clinical neurology manuals. His cutting-edge contributions, including transcranial drug delivery devices, underscore his commitment to advancing global healthcare. 🌍📚

Publication Profile

google scholar

Academic and Professional Background

Professor Yilong Wang 🎓, an accomplished neurologist, earned his MBBS and MSc from North China University of Science and Technology, followed by an MD and PhD in Neurology from Capital Medical University. He completed postdoctoral training at the University of San Francisco 🌉. Currently serving as Executive Vice President and Chief Scientist at Beijing Tiantan Hospital 🏥, Prof. Wang has led groundbreaking research in stroke and rare neurological diseases 🧠. Over the past five years, he has published 72 high-impact papers 📄, holds 12 patents, and made significant strides in precision medicine and drug delivery systems 💊, earning prestigious accolades like the 2023 Paul Dudley White International Award 🏆.

Editorial Appointments

 Professor Yilong Wang 🧑‍⚕️ holds prominent editorial roles, serving as the Assistant Editor-in-Chief of Stroke & Vascular Neurology 📚, Deputy Editor-in-Chief of the Chinese Journal of Cerebrovascular Diseases 🧠, and as an editorial board member of the Chinese Journal of Stroke ✍️. His collaborative efforts extend to leading institutions, including the Frontier Medical Interdisciplinary and Translational Center at the National Center for Neurological Disorders 🌐 and the Beijing Brain Science and Brain-Inspired Research Center 🧬. These partnerships underscore his commitment to advancing neurological research and fostering innovation in cerebrovascular and brain science 🏥.

Professional Memberships

Professor Yilong Wang 🧑‍⚕️ plays key leadership roles in various prestigious organizations. He serves as Vice Chairman of the Expert Committee for the National Health Commission’s Million Disability Reduction Project 🌟, demonstrating his dedication to public health. Prof. Wang is also the Deputy Leader of the Youth Group of the 8th Committee of the Neurology Branch of the Chinese Medical Association 🧠. Additionally, he is the Executive Vice Chairman of the Youth Working Committee of the Chinese Stroke Association 💼 and Vice Chairman of the Cerebral Small Vessel Disease Branch of the Chinese Stroke Association 🩺, driving innovation in neurological care.

Areas of Research

Professor Yilong Wang 🧑‍⚕️ specializes in clinical and translational research on cerebrovascular diseases and rare neurological disorders 🧠, with a focus on interdisciplinary medical-engineering innovations ⚙️. His research includes precision medicine for ischemic stroke 🩺, developing technologies for accurate diagnosis and treatment. He pioneers innovative drug delivery systems 💊, utilizing skull bone marrow-dura-lymphatic pathways to bypass the blood-brain barrier for safe intracranial drug delivery. Prof. Wang also investigates the pathogenesis, diagnostics, and interventions for cerebral small vessel disease and rare neurological disorders 🌐. Additionally, he advances intelligent skull flaps, smart drug delivery systems, and brain-computer interfaces 🤖.

Contributions

Professor Yilong Wang 🧑‍⚕️, a renowned neurologist at Beijing Tiantan Hospital 🏥, has revolutionized stroke and rare neurological disease research 🧠. Over the past five years, he has published 72 high-impact papers in top journals like NEJM, JAMA, and BMJ 📄 and holds 12 patents, with 2 successfully translated into clinical applications 🌟. His innovations include extending the time window for dual antiplatelet therapy, developing drugs for microcirculation disorders, and pioneering skull-based drug delivery systems to bypass the blood-brain barrier 💊. Recipient of the 2023 Paul Dudley White International Award 🏆, Prof. Wang has advanced precision medicine and rare disease research, improving global patient care 🌍.

Research Focus

Professor Yilong Wang is a distinguished researcher focusing on neurology, particularly stroke epidemiology, prevention, and management, and the application of artificial intelligence (AI) in healthcare. His work spans from analyzing stroke prevalence in China to exploring treatment strategies, including antiplatelet therapies and real-world applications of AI in medical practice. With a robust emphasis on stroke prevention, outcomes, and treatment innovation, his contributions bridge advanced research and clinical practice. Wang’s research also addresses the broader implications of healthcare technologies, underscoring their transformative potential. 🧠💊📊

Publication Top Notes

Artificial intelligence in healthcare: past, present and future

Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults

Clopidogrel with aspirin in acute minor stroke or transient ischemic attack

Stroke in China: advances and challenges in epidemiology, prevention, and management

Near-real-time monitoring of global CO2 emissions reveals the effects of the COVID-19 pandemic

Rivaroxaban for stroke prevention after embolic stroke of undetermined source

Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) Study

Summer soil drying exacerbated by earlier spring greening of northern vegetation

 

Prof Dr. THAWATCHAI PHAECHAMUD| Drug Delivery Systems | Best Researcher Award-1299

Published on by Top Pharmaceutical

Prof Dr. THAWATCHAI PHAECHAMUD, Drug Delivery Systems ,Best Researcher Award

Prof Dr. THAWATCHAI PHAECHAMUD atSilpakorn University,Thailand

PROFILE  

Google scholar 

Scopus

Orcid

Early Academic Pursuits 🎓

Thawatchai Phaechamud, Mr., embarked on his academic journey at the Faculty of Pharmacy, Silpakorn University, Thailand, where he earned his Bachelor of Pharmacy (B.Pharm) degree in 1991. Demonstrating a strong interest in pharmaceutical sciences from an early stage, he advanced his studies at the Faculty of Pharmaceutical Sciences, Chulalongkorn University. There, he completed his Master of Science (M.Sc.) in Manufacturing Pharmacy in 1995, with a thesis focused on the “Effect of variables in chitosan film on propranolol hydrochloride coated tablets.” His academic journey culminated in a Ph.D. in Pharmaceutics from the same institution in 1999. His doctoral thesis, titled “Film-coating of chitosan onto propranolol hydrochloride tablet: Approach to fast and extended drug release,” laid the foundation for his future contributions to the field of pharmaceutics, particularly in drug delivery systems.

Professional Endeavors 🧑‍🏫

Mr. Phaechamud began his professional career as a Lecturer at the Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, from 1991 to 1993. During this period, he honed his teaching skills and laid the groundwork for a lifelong commitment to academia. From 1994 to 1996, he served as a research student at the Faculty of Pharmaceutical Sciences, Chulalongkorn University, further deepening his research capabilities. His academic prowess earned him a position as a Visiting Scientist at the Department of Pharmaceutics, Toyama Medical & Pharmaceutical University in Japan from November 1997 to January 1998.

Upon completing his Ph.D., Mr. Phaechamud returned to Silpakorn University, where he served as an Assistant Professor from 1999 to 2003 in the Department of Pharmaceutical Technology. His dedication to teaching and research led to his promotion to Associate Professor in 2004, a position he has held ever since. His roles have expanded over the years, including serving as the Head of the Department of Pharmaceutical Technology from 2008 to 2009 and Chairman of the Pharmaceutical Engineering Doctoral Program from 2017 to 2018. Since 2018, Mr. Phaechamud has held the esteemed title of Professor in the Department of Industrial Pharmacy, Faculty of Pharmacy at Silpakorn University.

Contributions and Research Focus 🔬

Mr. Phaechamud’s research interests are diverse, focusing on various aspects of pharmaceutical sciences. His work primarily revolves around controlled drug delivery systems, in situ forming gels, matrix film and tablet characterizations, herbal preparation and development, pharmaceutical film coating, and pharmaceutical excipient characterization. He has made significant contributions to the development of controlled drug delivery systems, a field that aims to enhance the efficacy and safety of medications by controlling the rate, time, and place of drug release.

His expertise in polymeric film characterization and pharmaceutical excipient characterization has been instrumental in advancing the understanding of drug delivery mechanisms. His work on in situ forming gels and matrix films has paved the way for innovative drug delivery solutions, particularly in the treatment of chronic conditions where sustained drug release is crucial.

Accolades and Recognition 🏆

Throughout his illustrious career, Mr. Phaechamud has received numerous accolades and recognition for his contributions to pharmaceutical sciences. In June 2006, he was honored as a TRF Research Scholar by The Thailand Research Fund, a prestigious recognition of his research excellence. His leadership in the “Development of standard extract of SC for pharmaceutical and cosmetic applications” research program at Silpakorn University in 2008-2009 further solidified his reputation as a leading researcher in his field.

His publications in high-impact journals reflect the quality and impact of his research. Notable publications include works in the International Journal of Biological Macromolecules, Polymers, AAPS PharmSciTech, and Pharmaceutics, where his research on topics such as transdermal and periodontal pocket drug delivery systems, in situ gels, and solvent-removal zein-based in situ gels has garnered significant attention.

Impact and Influence 🌍

Mr. Phaechamud’s research has had a profound impact on the field of pharmaceutics, particularly in the area of drug delivery systems. His work on controlled drug delivery systems and in situ forming gels has influenced the development of new therapeutic approaches that improve patient outcomes by ensuring more effective and targeted drug delivery.

His influence extends beyond research; as an educator, he has mentored countless students, many of whom have gone on to become leaders in the pharmaceutical industry and academia. His teachings on modified release solid dosage forms, controlled drug delivery systems, and polymer degradation have been instrumental in shaping the next generation of pharmaceutical scientists.

Legacy and Future Contributions 🌟

Mr. Phaechamud’s legacy is one of innovation, dedication, and excellence in the field of pharmaceutical sciences. His work has not only advanced the understanding of drug delivery mechanisms but also paved the way for new therapeutic solutions that have the potential to improve the lives of millions of patients worldwide.

As he continues his work at Silpakorn University, Mr. Phaechamud is

🎓Publication 

Moist heat treatment on physicochemical change of chitosan salt films

  • Authors   :Garnpimol C Ritthidej, Thawatchai Phaechamud, Tamotsu Koizumi
  • Journal    :International journal of pharmaceutics
  • Year         :2002

Gentamicin sulfate-loaded porous natural rubber films for wound dressing

    • Authors :Thawatchai Phaechamud, Pongsathorn Issarayungyuen, Wiwat Pichayakorn
    • Journal   :International journal of biological macromolecules
    • Year       : 2016

Sustained-release from layered matrix system comprising chitosan and xanthan gum

  • Authors  :Thawatchai Phaechamud, Garnpimol C Ritthidej
  • Journal    :Drug development and industrial pharmacy
  • Year         :  2007

The study of antioxidant capacity in various parts of Areca catechu L.

  • Authors  :Penpun Wetwitayaklung, Thawatchai Phaechamud, Chutima Limmatvapirat, Sindhchai Keokitichai
  • Journal   :Naresuan University Journal: Science and Technology (NUJST)
  • Year        :   2006

Antibacterial activity and drug release of chitosan sponge containing doxycycline hyclate

  • Authors  :Thawatchai Phaechamud, Juree Charoenteeraboon
  • Journal   :Aaps PharmSciTech
  • Year        :  2008

Prof Dr.Dinesh Mishra, Drug Delivery Systems,Best Researcher Award

Published on by Top Pharmaceutical

Prof Dr.Dinesh Mishra, Drug Delivery Systems ,Best Researcher Award

Prof Dr.Dinesh Mishra, atDepartment of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur,India

Author Profile

 

Educational Background

Dr. Dinesh Kumar Mishra holds a Ph.D. in Pharmaceutics from Dr. H. S. Gour University, Sagar, where he studied under the supervision of Prof. N. K. Jain. He completed his M. Pharm. in Pharmaceutics from the same institution, achieving a merit-holder distinction. Dr. Mishra’s academic journey began with a B. Pharm. degree from Dr. H. S. Gour University, followed by secondary education credentials from the M.P. Board.

Professional Experience

Dr. Mishra has an extensive teaching and administrative career spanning over two decades. He is currently a Professor at Guru Ghasidas Vishwavidyalaya, a position he has held since July 2023. Prior to this, he served as Principal and Professor at Indore Institute of Pharmacy and held various academic roles at NMIMS, IPS Academy, SLT Institute of Pharmaceutical Sciences, Mahakal Institute of Pharmaceutical Studies, Shri Ram Institute of Technology, and AND College of Pharmacy.

Teaching and Administrative Roles

  • UG Teaching Experience: 21 years
  • PG Teaching Experience: 19 years
  • Principal at Indore Institute of Pharmacy: 4 years
  • HOD, M. Pharm (Pharmaceutics): 8 years
  • Exam Center Superintendent, IPS Academy College of Pharmacy: 2 years
  • Academic In-charge, IPS Academy College of Pharmacy: 2 years

Research Credentials

Dr. Mishra’s research credentials are noteworthy, with a cumulative impact factor of 245, 4700 citations, an h-index of 38, and an i-10 index of 58. He has guided numerous students at both undergraduate and postgraduate levels, as well as Ph.D. candidates.

Ph.D. Research Supervision

  1. Dr. Shriprakash Mishra – Development of mucoadhesive microsphere for the treatment of peptic ulcer (Awarded)
  2. Mr. Pritam R. Siraskar – Formulation, characterization, and optimization of gastro retentive floating microspheres using quality by design approach (Awarded)
  3. Mr. Devkant Sharma – Formulation, evaluation, and optimization of nanotechnology-based drug delivery system for psoriasis treatment (Awarded)
  4. Ms. Nayany Sharma – Development of silver nanoparticles-based topical gel containing herbal actives for wound healing
  5. Ms. Neha Kamalpuria – Formulation, optimization, and evaluation of lipid-based nanocarrier gel for topical drug delivery
  6. Ms. Triveni – Design, optimization, and characterization of antifungal drug loaded transferosome based hydrogels for the management of foot dermatophytosis

Honors and Awards

Dr. Mishra has received numerous accolades for his contributions to pharmaceutical sciences, including being listed among the world’s top 2% scientists by Elsevier in 2022 and 2023. He has also received several prestigious awards such as the Prof. M. L. Schroff Pharma Recognition Award, the Outstanding Scientist Award, the Best Scientist Award, and the Eminent Principal Award.

Collaborations and Grants

Dr. Mishra has collaborated with notable institutions such as NIPER Ahmedabad, NIREH ICMR Bhopal, and Central University of Rajasthan. He has successfully secured research grants from various bodies, including MPCST, AICTE, NMIMS University, and UGC-BSR.

Professional Memberships
He is a life member of several esteemed professional bodies including APTI, IPA, ISCA, IPGA, APP, SPER, and ISSRF.

🎓Publication Top Noted:

Paper Title :Full factorial design-based development and characterization of ciclopirox olamine loaded transferosomes: An efficient approach for the management of Athlete’s foot

  • Authors:Triveni, Upendra Nagaich, Dinesh Kumar Mishra, Neha Jain
  • Journal:Journal of Drug Delivery Science and Technology
  • Year: 2024
Paper Title :New emerging technologies for genetic toxicity testing
    • Authors: Kuldeep Vinchurkar, Jitendra Sainy, Masheer Ahmed Khan, Sheetal Mane, Dinesh K. Mishra, Pankaj Dixit
    • Journal:Pharmacokinetics and Toxicokinetic Considerations
    • Year: 2022
Paper Title :Features and Facts of a Gastroretentive Drug Delivery System-A Review
  • Authors:Kuldeep Vinchurkar, Jitendra Sainy, Masheer Ahmed Khan, Sheetal Mane, Dinesh K. Mishra, Pankaj Dixit
  • Journal:Turkish Journal of Pharmaceutical Sciences
  • Year:2022
Paper Title :3D Printing for Drug Delivery and its Pharmaceutical Applications – Recent Findings and Challenges
  • Authors: Kuldeep Vinchurkar, Jitendra Sainy, Masheer Ahmed Khan, Sheetal Mane, Dinesh K. Mishra, Pankaj Dixit
  • Journal: International Journal of Pharmaceutical Sciences and Nanotechnology
  • Year: 2022

Paper Title :Recent update of toxicity aspects of nanoparticulate systems for drug delivery

  • Authors: Patnaik, S., Gorain, B., Padhi, S., Choudhury, H., Gabr, G.A., Md, S., Kumar Mishra, D., Kesharwani, P.
  • Journal:European Journal of Pharmaceutics and Biopharmaceutics
  • Year:2021